Related Experiment Video
Updated: May 27, 2025

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Germline Variants in Pediatric Cancer : Based on Oncogenic Pathways
Joo Whan Kim1,2
1Division of Pediatric Neurosurgery, Seoul National University Children's Hospital, Seoul National University College of Medicine, Seoul, Korea.
Pathogenic germline variants (PGVs) are key in pediatric cancer. Understanding these genetic changes, often inherited, aids in early detection and personalized treatment for childhood cancers.
Area of Science:
- Genomic Medicine
- Pediatric Oncology
- Cancer Genomics
Background:
- Pathogenic germline variants (PGVs) are increasingly recognized in pediatric cancer predisposition.
- Next-generation sequencing and genome databases are advancing the understanding of cancer genomics.
- PGVs play roles in key oncogenic pathways like RTK/RAS/MAPK, PI3K/AKT, WNT, and Hedgehog signaling.
Purpose of the Study:
- To review the role of PGVs in pediatric cancer predisposition syndromes.
- To highlight neurosurgical implications of PGVs.
- To emphasize the importance of germline screening and genomic databases for personalized medicine.
Main Methods:
- Review of existing literature on PGVs in pediatric cancer.
- Analysis of PGVs in specific oncogenic pathways and associated syndromes.
- Discussion of the prevalence and inheritance patterns of PGVs.
Main Results:
- PGVs are associated with various cancer predisposition syndromes, often inherited dominantly.
- RASopathies and syndromes like Cowden and DICER1 are linked to specific PGVs.
- Approximately 8.5-20% of pediatric cancer patients harbor PGVs, with many arising de novo.
Conclusions:
- Routine germline screening for pediatric cancer patients is recommended due to de novo occurrences and lack of family history.
- Comprehensive pediatric genome databases are crucial for personalized precision medicine.
- International collaboration is needed to advance pediatric cancer genomics for improved diagnostics, therapeutics, and prevention.
Related Concept Videos
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancers Originate from Somatic Mutations in a Single Cell
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

